Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin-clavulanate (7:1) vs (5:1) in lower respiratory and urinary tract infections
CTR20131000Phase 3Active
- Sponsor
- Xiangbei Welman Pharmaceuticals
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amoxicillin + clavulanate in pulmonary infection, Symptomatic Bacteriuria, sponsored by Xiangbei Welman Pharmaceuticals. Started Mar 2014; status: active.
02
Drugs
amoxicillin + clavulanate
03
Conditions
pulmonary infectionSymptomatic Bacteriuria
Beyond the preview
Go deeper on CTR20131000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131000.